Feed 6535.TWO
65
Lumosa Therapeutics Co., Ltd.
6535.TWO · TWO
$88.20 -4.23% (-$3.90)
1M -6.31%
Market Cap $15.4B
P/E Ratio -
Div. Yield -
ROE 21.61%
Valuation
0 /100
Expensive P/B 10.21x
P/S 430.04x
P/FFO N/A
Growth
56 /100
Stable Book val. growth 2.52%
Rev. growth 10.38%
FCF growth N/A
Profitability
20 /100
Weak Net margin 967.37%
Op. margin 930.73%
FCF margin 996.55%
Quality
0 /100
Poor ROE 21.61%
ROA 21.00%
Asset turnover 0.02x
Debt
69 /100
Low Current ratio 7.37x
Int. coverage -1,659.15x
Debt/Equity 0.00x
Stability
6 /100
Unstable Rev. volatility 77.90%
EPS volatility 67.58%
Profitable years 0
Vprašajte StockBota o 6535.TWO
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Jung Chin Lin
Employees
36
Headquarters
Taipei
Prihajajoči dogodki
05 NOV.
Earnings
Upcoming earnings report